Transient and Selective Overexpression of Dopamine D2 Receptors in the Striatum Causes Persistent Abnormalities in Prefrontal Cortex Functioning

Cited by (521)

Items 201–300 of 521

1. The relationship between antipsychotic D2 occupancy and change in frontal metabolism and working memory
   Euitae Kim, Oliver David Howes, Federico Turkheimer, Bo‐Hyung Kim, Jae Min Jeong, Ju Whi Kim, Jae Sung Lee, In‐Jin Jang, Sang‐Goo Shin, Shitij Kapur et al. · 2012 · Psychopharmacology
2. Activating Developmental Reserve Capacity Via Cognitive Training or Non-invasive Brain Stimulation: Potentials for Promoting Fronto-Parietal and Hippocampal-Striatal Network Functions in Old Age
   Susanne Passow, Franka Thurm, Shu Li · 2017 · Frontiers in Aging Neuroscience
3. Dopamine, Cognitive Impairments and Second-Generation Antipsychotics: From Mechanistic Advances to More Personalized Treatments
   Sebastiano Alfio Torrisi, Samuele Laudani, Gabriella Contarini, Angelina De Luca, Federica Geraci, Francesca Managò, Francesco Papaleo, Salvatore Salomone, Filippo Drago, Gian Marco Leggio · 2020 · Pharmaceuticals
4. Gene Expression in the Etiology of Schizophrenia
   Nicholas J. Bray · 2007 · Schizophrenia Bulletin
5. Functional Homomers and Heteromers of Dopamine D2L and D3 Receptors Co-exist at the Cell Surface
   Chantévy Pou, Clotilde Mannoury la Cour, Leigh A. Stoddart, Mark John Millan, Graeme Milligan · 2012 · Journal of Biological Chemistry
6. Schizophrenia: A developmental disorder with a risk of non-specific but avoidable decline
   Robin M. Murray, Emre Bora, Gemma Modinos, Anthony Christopher Vernon · 2022 · Schizophrenia Research
7. Refinement of diagnosis and disease classification in psychiatry
   Yves Lecrubier · 2008 · European Archives of Psychiatry and Clinical Neuroscience
8. PET Evidence for a Role for Striatal Dopamine in the Attentional Blink: Functional Implications
   Heleen A. Slagter, Rachel Tomer, Bradley T. Christian, Andrew S. Fox, Lorenza S. Colzato, Carlye R. King, Dhanabalan Murali, Richard J. Davidson · 2012 · Journal of Cognitive Neuroscience
9. Altered dopamine ontogeny in the developmentally vitamin D deficient rat and its relevance to schizophrenia
   J. Kesby, Xiao-Ying Cui, T. Burne, D. Eyles · 2013 · Frontiers in Cellular Neuroscience
10. Striatal dopamine 2 receptor upregulation during development predisposes to diet-induced obesity by reducing energy output in mice
    Marie A. Labouesse, Andrea M. Sartori, Oliver Weinmann, Eleanor H. Simpson, Christoph Kellendonk, Ulrike Weber‐Stadlbauer · 2018 · Proceedings of the National Academy of Sciences
11. Cell-type-specific regulation of neuronal intrinsic excitability by macroautophagy
    Ori J. Lieberman, Micah D. Frier, Avery F. McGuirt, Christopher J. Griffey, Elizabeth E. Rafikian, Mu Yang, Ai Yamamoto, Anders Borgkvist, Emanuela Santini, David Sulzer · 2020 · eLife
12. Decreased striatal adenosine A2A-dopamine D2 receptor heteromerization in schizophrenia
    Marta Valle-León, Luis Felipe Callado, Ester Aso, María del Mar Cajiao-Manrique, Kristoffer Sahlholm, Marc López‐Cano, Concepció Soler, Xavier Altafaj, Masahiko Watanabe, Sergi Ferré et al. · 2020 · Neuropsychopharmacology
13. Differential Repression by Freud-1/CC2D1A at a Polymorphic Site in the Dopamine-D2 Receptor Gene
    Anastasia Rogaeva, Xiao‐Ming Ou, Hamed Jafar‐Nejad, Sylvie Lemonde, Paul R. Albert · 2007 · Journal of Biological Chemistry
14. mTORC2/Rictor Signaling Disrupts Dopamine-Dependent Behaviors via Defects in Striatal Dopamine Neurotransmission
    Olga I. Dadalko, Michael Siuta, Abigail Anne Poe, Kevin Erreger, Heinrich J. G. Matthies, Kevin Dean Niswender, Aurelio Galli · 2015 · Journal of Neuroscience
15. Insights About Striatal Circuit Function and Schizophrenia From a Mouse Model of Dopamine D2 Receptor Upregulation
    Eleanor H. Simpson, Christoph Kellendonk · 2016 · Biological Psychiatry
16. The dynamics of disordered dialogue: Prefrontal, hippocampal and thalamic miscommunication underlying working memory deficits in schizophrenia
    David A. Kupferschmidt, Joshua A. Gordon · 2018 · Brain and Neuroscience Advances
17. The role of animal models in evaluating reasonable safety and efficacy for human trials of cell-based interventions for neurologic conditions
    Alan Regenberg, D. Mathews, D. M. Blass, H. Bok, J. Coyle, P. Duggan, R. Faden, J. Finkel, John D. Gearhart, A. Hillis et al. · 2008 · Journal of Cerebral Blood Flow and Metabolism
18. Contributions of signaling by dopamine neurons in dorsal striatum to cognitive behaviors corresponding to those observed in Parkinson's disease
    Martin Darvas, Charles W. Henschen, Richard D. Palmiter · 2014 · Neurobiology of Disease
19. Dopamine D2 Receptors in the Paraventricular Thalamus Attenuate Cocaine Locomotor Sensitization
    Abigail M. Clark, Félix Leroy, Kelly Marie Martyniuk, Wendy Feng, Erika McManus, Matthew R. Bailey, Jonathan A. Javitch, Peter D. Balsam, Christoph Kellendonk · 2017 · eNeuro
20. Haloperidol and clozapine have dissociable effects in a model of attentional performance deficits induced by blockade of NMDA receptors in the mPFC
    Marta Baviera, Roberto William Invernizzi, Mirjana Carli · 2007 · Psychopharmacology
21. Dopamine D1 sensitivity in the prefrontal cortex predicts general cognitive abilities and is modulated by working memory training
    Christopher Wass, Alessandro Pizzo, Bruno Sauce, Yushi Kawasumi, Tudor Sturzoiu, Fredrick Ree, Tim Otto, Louis D. Matzel · 2013 · Learning & Memory
22. Schizophrenia Exhibits Bi-directional Brain-Wide Alterations in Cortico-Striato-Cerebellar Circuits
    Jie Lisa Ji, Caroline Diehl, Charles H. Schleifer, Carol A. Tamminga, Matcheri S. Keshavan, John A. Sweeney, Brett A. Clementz, S. Kristian Hill, Godfrey D. Pearlson, Genevieve Yang et al. · 2018 · Cerebral Cortex
23. Features of compulsive checking behavior mediated by nucleus accumbens and orbital frontal cortex
    Anna Dvorkin‐Gheva, Charmaine Silva, Thomas McMurran, Liane Bisnaire, Jane Allyson Foster, Henry Szechtman · 2010 · European Journal of Neuroscience
24. Alterations of GABAergic and dopaminergic systems in mutant mice with disruption of exons 2 and 3 of the Disc1 gene
    T. NAKAI, Taku Nagai, Rui Wang, Shinnosuke Yamada, Keisuke Kuroda, Kozo Kaibuchi, Kiyofumi Yamada · 2014 · Neurochemistry International
25. The epistatic interaction between the dopamine D3 receptor and dysbindin-1 modulates higher-order cognitive functions in mice and humans
    Gian Marco Leggio, Sebastiano Alfio Torrisi, Rosa Mastrogiacomo, D. Mauro, Mariangela Chisari, Céline Devroye, Diego Scheggia, Marco Nigro, F. Geraci, Nicholas Pintori et al. · 2019 · Molecular Psychiatry
26. Prefrontal and Striatal Dopamine Release Are Inversely Correlated in Schizophrenia
    William Gordon Frankle, Michael L. Himes, Neale Scott Mason, Chester A. Mathis, Rajesh Narendran · 2022 · Biological Psychiatry
27. Modeling motivational deficits in mouse models of schizophrenia: Behavior analysis as a guide for neuroscience
    Ryan D. Ward, Eleanor H. Simpson, Eric R. Kandel, Peter D. Balsam · 2011 · Behavioural Processes
28. Up‐regulation of dopamine D2L mRNA levels in the ventral tegmental area and dorsal striatum of amphetamine‐sensitized C57BL/6 mice: role of Cav1.3 L‐type Ca2+ channels
    T. P. Giordano, Shirish S. Satpute, Jörg Striessnig, Barry E. Kosofsky, Anjali M. Rajadhyaksha · 2006 · Journal of Neurochemistry
29. Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia
    Kärt Mätlik, Daniel R. Garton, Ana Montaño-Rodriguez, Soophie Olfat, Feride Eren, Laoise Casserly, Anastasios E. Damdimopoulos, Anne E. Panhelainen, L. Lauriina Porokuokka, Jaakko J. Kopra et al. · 2022 · Molecular Psychiatry
30. Avoiding mouse traps in schizophrenia genetics: lessons and promises from current and emerging mouse models
    Mirna Kvajo, Heather McKellar, Joseph A. Gogos · 2011 · Neuroscience
31. Modeling Deficits in Attention, Inhibition, and Flexibility in HAND
    Landhing M. Moran, Rosemarie M. Booze, Charles F. Mactutus · 2014 · Journal of Neuroimmune Pharmacology
32. A Thalamic Orphan Receptor Drives Variability in Short-Term Memory
    Kuangfu Hsiao, Chelsea Noble, Wendy A. Pitman, Nakul Yadav, Suraj Kumar, Gregory R. Keele, Andrea Araceli Terceros, Matt Kanke, Tara Conniff, Christopher Cheleuitte-Nieves et al. · 2020 · Cell
33. Annual Research Review: New frontiers in developmental neuropharmacology: can long‐term therapeutic effects of drugs be optimized through carefully timed early intervention?
    Susan L. Andersen, Carryl P. Navalta · 2011 · Journal of Child Psychology and Psychiatry
34. Possible involvement of post-dopamine D2 receptor signalling components in the pathophysiology of schizophrenia
    Shirly Amar, Galit Shaltiel, Liad Mann, Alon Shamir, Brian Dean, Elizabeth Scarr, Yuly Bersudsky, R.H. Belmaker, Galila Agam · 2007 · The International Journal of Neuropsychopharmacology
35. Behavioral Animal Models of Antipsychotic Drug Actions
    Daria Peleg‐Raibstein, Joram Feldon, Urs Meyer · 2012 · Handbook of experimental pharmacology
36. Electrophysiological Endophenotypes in Rodent Models of Schizophrenia and Psychosis
    Andrew M. Rosen, Timothy Spellman, Joshua A. Gordon · 2015 · Biological Psychiatry
37. New functional activity of aripiprazole revealed: Robust antagonism of D2 dopamine receptor-stimulated Gβγ signaling
    Tarsis F. Brust, Michael Patrick Hayes, David L. Roman, Val J. Watts · 2014 · Biochemical Pharmacology
38. Animal models of schizophrenia for molecular and pharmacological intervention and potential candidate molecules
    Akihiro Mouri, Taku Nagai, Daisuke Ibi, Kiyofumi Yamada · 2012 · Neurobiology of Disease
39. Dopamine Receptor Excess and Mouse Madness
    Solomon H. Snyder · 2006 · Neuron
40. Advancing a functional genomics for schizophrenia: Psychopathological and cognitive phenotypes in mutants with gene disruption
    Brian P. Kirby, John L. Waddington, Colm M. P. O’Tuathaigh · 2009 · Brain Research Bulletin
41. Transgenic mice overexpressing the extracellular domain of NCAM are impaired in working memory and cortical plasticity
    Leann H. Brennaman, Gaga Kochlamazashvili, Luminita Stoenica, Randal J. Nonneman, Sheryl S. Moy, Melitta Schachner, Alexander E. Dityatev, Patricia F. Maness · 2011 · Neurobiology of Disease
42. Impaired recruitment of dopamine neurons during working memory in mice with striatal D2 receptor overexpression
    Sevil Duvarci, Eleanor H. Simpson, Gaby Schneider, Eric R. Kandel, Jochen Roeper, Torfi Sigurdsson · 2018 · Nature Communications
43. Incorporating Physiological and Biochemical Mechanisms into Pharmacokinetic–Pharmacodynamic Models: A Conceptual Framework*
    Svein G. Dahl, Leon J Aarons, Ursula Gundert‐Remy, Mats O. Karlsson, Yves‐Jacques Schneider, Jean‐Louis Steimer, Iñaki F. Trocóniz · 2009 · Basic & Clinical Pharmacology & Toxicology
44. The effect of COMT Val158Met and DRD 2 C957T polymorphisms on executive function and the impact of early life stress
    Kristel Klaus, Kevin Butler, Simon J. Durrant, Manir Ali, Chris F. Inglehearn, Timothy L. Hodgson, Humberto Gutiérrez, Kyla Pennington · 2017 · Brain and Behavior
45. Disentangling the diverse roles of dopamine D2 receptors in striatal function and behavior
    Eduardo F. Gallo · 2019 · Neurochemistry International
46. Task-induced functional brain connectivity mediates the relationship between striatal D2/3 receptors and working memory
    Matthew M. Nour, Tarik Dahoun, Robert Ali McCutcheon, Rick A. Adams, Matthew B. Wall, Oliver David Howes · 2019 · eLife
47. Quantifying the inverted U: A meta-analysis of prefrontal dopamine, D1 receptors, and working memory.
    Matthew A. Weber, Mackenzie M. Conlon, Hannah R Stutt, Linder Hagstrom Wendt, Patrick Ten Eyck, Nandakumar S. Narayanan · 2022 · Behavioral Neuroscience
48. The dopaminergic basis of cognitive and motor performance in Alzheimer's disease
    Suzanne Reeves, Mitul Ashok Mehta, Robert J. Howard, Paul M. Grasby, Richard G. Brown · 2009 · Neurobiology of Disease
49. The nucleus accumbens and alcoholism: a target for deep brain stimulation
    Allen Lin Ho, Anne-Mary N. Salib, Arjun Vivek Pendharkar, Eric Scott Sussman, William J. Giardino, Casey H. Halpern · 2018 · Neurosurgical FOCUS
50. Cognitive Flexibility Training Improves Extinction Retention Memory and Enhances Cortical Dopamine With and Without Traumatic Stress Exposure
    Lauren E. Chaby, Klevis Karavidha, Michael J. Lisieski, Shane Alan Perrine, Israel Liberzon · 2019 · Frontiers in Behavioral Neuroscience
51. Evidence of sexual dimorphism in D1 and D2 dopaminergic receptors expression in frontal cortex and striatum of young rats
    Erika Nallely Orendain-Jaime, Jorge Ortega‐Ibarra, Silvia Josefina López‐Pérez · 2016 · Neurochemistry International
52. Better understanding of mechanisms of schizophrenia and bipolar disorder: From human gene expression profiles to mouse models
    Chi-Ying Lin, Akira Sawa, Hanna Jaaro-Peled · 2011 · Neurobiology of Disease
53. PKCα-mediated phosphorylation of LSD1 is required for presynaptic plasticity and hippocampal learning and memory
    Chae‐Seok Lim, Hye Jin Nam, Jaehyun Lee, Dong Ha Kim, Ja Eun Choi, SukJae Joshua Kang, Somi Kim, Hyopil Kim, Chuljung Kwak, Kyu-Won Shim et al. · 2017 · Scientific Reports
54. Blockade of Rapid Influx of Extracellular Zn2+ into Nigral Dopaminergic Neurons Overcomes Paraquat-Induced Parkinson’s Disease in Rats
    Haruna Tamano, Hiroki Morioka, Ryusuke Nishio, Azusa Takeuchi, Atsushi Takeda · 2018 · Molecular Neurobiology
55. Maternal Exposure to Dietary Selenium Causes Dopaminergic Hyperfunction and Cognitive Impairment in Zebrafish Offspring
    Mohammad Naderi, Maud C. O. Ferrari, Douglas P. Chivers, Som Niyogi · 2018 · Environmental Science & Technology
56. Striatal dopamine D2 receptors regulate effort but not value-based decision making and alter the dopaminergic encoding of cost
    Ina Filla, Matthew R. Bailey, Elke S Schipani, Vanessa Winiger, Chris Mezias, P. Balsam, E. Simpson · 2018 · Neuropsychopharmacology
57. The Detection of Novelty Relies on Dopaminergic Signaling: Evidence from Apomorphine's Impact on the Novelty N2
    Mauricio Rangel‐Gomez, Clayton Hickey, Thérèse van Amelsvoort, Pierre M. Bet, Martijn Meeter · 2013 · PLoS ONE
58. The KBTBD6/7-DRD2 axis regulates pituitary adenoma sensitivity to dopamine agonist treatment
    Yan Ting Liu, Fang Liu, Lei Cao, Xue Li, Wei Ting Gu, Yong Zhi Zheng, Hao Tang, Yu Wang, Hong Wei Yao, Yong Zhang et al. · 2020 · Acta Neuropathologica
59. Dystrophic dendrites in prefrontal cortical pyramidal cells of dopamine D1 and D2 but not D4 receptor knockout mice
    Hui Dong Wang, Gregg D. Stanwood, David K. Grandy, Ariel Y. Deutch · 2009 · Brain Research
60. Dopamine Receptor Interacting Proteins: Targeting Neuronal Calcium Sensor-1/D2 Dopamine Receptor Interaction for Antipsychotic Drug Development
    Nadine Kabbani, Mathew P. Woll, Jacob C. Nordman, Robert G. Levenson · 2011 · Current Drug Targets
61. Genetic variation in COMT activity impacts learning and dopamine release capacity in the striatum
    Eleanor H. Simpson, Julia Morud, Vanessa Winiger, Dominik Biezonski, Judy P. Zhu, Mary Elizabeth Bach, Gaël Malleret, H. Jonathan Polan, Scott Ng-Evans, Paul E. M. Phillips et al. · 2014 · Learning & Memory
62. Closing the translational gap between mutant mouse models and the clinical reality of psychotic illness
    Colm M. P. O’Tuathaigh, John L. Waddington · 2015 · Neuroscience & Biobehavioral Reviews
63. Circuit-Based Approaches to Understanding Corticostriatothalamic Dysfunction Across the Psychosis Continuum
    Kristina Sabaroedin, Jeggan Tiego, Alex Fornito · 2022 · Biological Psychiatry
64. Using human brain imaging studies as a guide toward animal models of schizophrenia
    Scott S. Bolkan, Fernanda Carvalho Poyraz, Christoph Kellendonk · 2015 · Neuroscience
65. KCNH2-3.1 expression impairs cognition and alters neuronal function in a model of molecular pathology associated with schizophrenia
    Gregory V. Carr, J Chen, F Yang, Ming Ren, P Yuan, Qu Tian, Audrey Bebensee, G Y Zhang, Jing Du, P Glineburg et al. · 2016 · Molecular Psychiatry
66. Epigenetic regulation of motivated behaviors by histone deacetylase inhibitors
    Lindsay Elvir, Florian Duclot, Zuoxin Wang, Mohamed Kabbaj · 2017 · Neuroscience & Biobehavioral Reviews
67. Genetics of autosomal recessive non‐syndromic mental retardation: recent advances
    Lina Basel‐Vanagaite · 2007 · Clinical Genetics
68. Disrupted working memory circuitry and psychotic symptoms in 22q11.2 deletion syndrome
    Caroline A. Montojo, Amira F.A. Ibrahim, Katherine H. Karlsgodt, Carolyn C. Chow, A.E. Hilton, Rachel K. Jonas, Therese Vesagas, Carrie E. Bearden · 2014 · NeuroImage Clinical
69. The D2 dopamine receptor gene variant C957T affects human fear conditioning and aversive priming
    Evelio Huertas, Guillermo Ponce, Alejandra Koeneke, Claudia Poch, Laura España‐Serrano, Tomás Palomo, Miguel Ángel Jiménez‐Arriero, Janet Hoenicka · 2009 · Genes Brain & Behavior
70. The Freud‐1/CC2D1A family: Transcriptional regulators implicated in mental retardation
    Anastasia Rogaeva, Kimberly Galaraga, Paul R. Albert · 2007 · Journal of Neuroscience Research
71. Functional magnetic resonance imaging investigation of the amphetamine sensitization model of schizophrenia in healthy male volunteers.
    O. O'Daly, D. Joyce, K. Stephan, R. Murray, S. Shergill · 2011 · Archives of General Psychiatry
72. The relationship between dopamine receptor blockade and cognitive performance in schizophrenia: a [11C]-raclopride PET study with aripiprazole
    Sang Ho Shin, Seoyoung Kim, Seongho Seo, Jae Sung Lee, Oliver David Howes, Euitae Kim, Jun Soo Kwon · 2018 · Translational Psychiatry
73. Potential role of adenosine A2A receptors in the treatment of schizophrenia.
    J. Wardas · 2008 · Frontiers in Bioscience
74. Emerging roles of striatal dopamine D2 receptors in motivated behaviour: Implications for psychiatric disorders
    Pedro R. Olivetti, Peter D. Balsam, Eleanor H. Simpson, Christoph Kellendonk · 2019 · Basic & Clinical Pharmacology & Toxicology
75. Local inactivation of Gpr88 in the nucleus accumbens attenuates behavioral deficits elicited by the neonatal administration of phencyclidine in rats
    Manuela Ingallinesi, L. Le Bouil, Nicole Faucon Biguet, A. Do Thi, Clotilde Mannoury la Cour, Mark John Millan, Philippe Ravassard, Jacques J. Mallet, Rolando Meloni · 2014 · Molecular Psychiatry
76. The moderating role of the dopamine transporter 1 gene on P50 sensory gating and its modulation by nicotine
    Anne Millar, Dylan Smith, Joëlle Choueiry, Derek J. Fisher, Paul R. Albert, Verner Knott · 2011 · Neuroscience
77. Motivational salience and genetic variability of dopamine D2 receptor expression interact in the modulation of interference processing
    Anni Richter, Sylvia Richter, Adriana Barman, Joram Soch, Marieke Klein, Anne Assmann, Catherine Libeau, Gusalija Behnisch, Torsten Wüstenberg, Constanze I. Seidenbecher et al. · 2013 · Frontiers in Human Neuroscience
78. Cholinergic depletion in nucleus accumbens impairs mesocortical dopamine activation and cognitive function in rats
    François Laplante, Zi-Wei Zhang, Frédéric Huppé‐Gourgues, Marc M. Dufresne, Elvire Vaucher, Ron M. Sullivan · 2012 · Neuropharmacology
79. The relationship between grey matter volume and striatal dopamine function in psychosis: a multimodal 18F-DOPA PET and voxel-based morphometry study
    Enrico D’Ambrosio, Sameer Jauhar, Seoyoung Kim, Mattia Veronese, Maria Rogdaki, Fiona Pepper, Ilaria Bonoldi, Vasileia Kotoula, Matthew J. Kempton, Federico Turkheimer et al. · 2019 · Molecular Psychiatry
80. Chronic haloperidol-induced spatial memory deficits accompany the upregulation of D1 and D2 receptors in the caudate putamen of C57BL/6 mouse
    Haiyun Xu, Hong-Ju Yang, Gregory M. Rose · 2012 · Life Sciences
81. Transient Downregulation of Dab1 Protein Levels during Development Leads to Behavioral and Structural Deficits: Relevance for Psychiatric Disorders
    Cátia M. Teixeira, Núria Masachs, Ashraf Muhaisen, Carles Bosch, F. Javier Pérez-Martínez, Brian W. Howell, Eduardo Soriano · 2013 · Neuropsychopharmacology
82. Knockdown of phospholipase C-β1 in the medial prefrontal cortex of male mice impairs working memory among multiple schizophrenia endophenotypes
    Seong-Wook Kim, Misun Seo, Duk‐Soo Kim, Moonkyung Kang, Yeon-Soo Kim, Hae-Young Koh, Hee‐Sup Shin · 2015 · Journal of Psychiatry and Neuroscience
83. Analysis of Human Dopamine D3 Receptor Quaternary Structure
    Sara Marsango, Gianluigi Caltabiano, Chantévy Pou, María José Varela Liste, Graeme Milligan · 2015 · Journal of Biological Chemistry
84. Improving temporal cognition by enhancing motivation.
    Billur Avlar, Julia B Kahn, Greg Jensen, Eric R. Kandel, Eleanor H. Simpson, Peter D. Balsam · 2015 · Behavioral Neuroscience
85. Serotonin and Dopamine Interactions in Rodents and Primates: Implications for Psychosis and Antipsychotic Drug Development
    Gerard J. Marek · 2007 · International review of neurobiology
86. Can we use mice to study schizophrenia?
    Sarah Canetta, Christoph Kellendonk · 2018 · Philosophical Transactions of the Royal Society B Biological Sciences
87. Paraquat as an Environmental Risk Factor in Parkinson’s Disease Accelerates Age-Related Degeneration Via Rapid Influx of Extracellular Zn2+ into Nigral Dopaminergic Neurons
    Haruna Tamano, Ryusuke Nishio, Hiroki Morioka, Ryo Furuhata, Yuuma Komata, Atsushi Takeda · 2019 · Molecular Neurobiology
88. Effects of Dopaminergic Drugs on Cognitive Control Processes Vary by Genotype
    Daniella J. Furman, Robert L. White, Jenna R. Naskolnakorn, Jean Ye, Andrew S. Kayser, Mark D’Esposito · 2020 · Journal of Cognitive Neuroscience
89. Altered states of consciousness and creativity
    Luisa Prochazkova, Bernhard Hommel · 2020 · Elsevier eBooks
90. Corticolimbic DCC gene co-expression networks as predictors of impulsivity in children
    Jose M. Restrepo-Lozano, Irina Pokhvisneva, Zihan Wang, Sachin H Patel, Michael Joseph Meaney, Patrícia Pelufo Silveira, Cecilia Flores · 2022 · Molecular Psychiatry
91. The effect of selective nigrostriatal dopamine excess on behaviors linked to the cognitive and negative symptoms of schizophrenia
    Nicolette A. Moya, Seongsik Yun, Stefan W. Fleps, Madison M. Martin, Jacob A. Nadel, Lisa R. Beutler, Larry S. Zweifel, Jones G. Parker · 2022 · Neuropsychopharmacology
92. Stuttering candidate genes DRD2 but not SLC6A3 is associated with developmental dyslexia in Chinese population
    Huan Chen, Guoqing Wang, Jiguang Xia, Yuxi Zhou, Yong Gao, Junquan Xu, Michael S.Y. Huen, Wai Ting Siok, Yuyang Jiang, Li Hai Tan et al. · 2014 · Behavioral and Brain Functions
93. From "bedside" to "bench" and back: A translational approach to studying dopamine dysfunction in schizophrenia.
    A. Abi-Dargham · 2020 · Neuroscience and Biobehavioral Reviews
94. Neuropsychopharmacology of Cognitive Flexibility
    Roshan Cools · 2015 · Elsevier eBooks
95. Integrated approaches to understanding antipsychotic drug action at GPCRs
    Nikhil M. Urs, PETER J. NICHOLLS, Marc G. Caron · 2013 · Current Opinion in Cell Biology
96. Gene–Gene Interaction Between COMT and MAOA Potentially Predicts the Intelligence of Attention-Deficit Hyperactivity Disorder Boys in China
    Qiujin Qian, Li Yang, Yufeng Wang, Hao-Bo Zhang, Li-Li Guan, Yun Chen, Ning Ji, Lu Liu, Stephen V. Faraone · 2009 · Behavior Genetics
97. Dopamine D1 receptor density in the mPFC responds to cognitive demands and receptor turnover contributes to general cognitive ability in mice
    Christopher Wass, Bruno Sauce, Alessandro Pizzo, Louis D. Matzel · 2018 · Scientific Reports
98. Assessment of cognitive functions in animal models of schizophrenia
    Agnieszka Nikiforuk · 2018 · Pharmacological Reports
99. Dopaminergic Perturbation in the Aetiology of Neurodevelopmental Disorders
    Olayemi Kafilat Ijomone, Rademene Sunday Oria, Omamuyovwi Meashack Ijomone, Michael Aschner, Julia Bornhorst · 2024 · Molecular Neurobiology
100. DRD2 methylation is associated with executive control network connectivity and severity of alcohol problems among a sample of polysubstance users
     Sarah L. Hagerty, Sophie L. YorkWilliams, L. Cinnamon Bidwell, Barbara J. Weiland, Amithrupa Sabbineni, Sara K. Blaine, Angela D. Bryan, Kent E. Hutchison · 2018 · Addiction Biology